[2-[(2R)-3-acetyl-2-[4-[(3-nitrobenzoyl)amino]phenyl]-2H-1,3,4-oxadiazol-5-yl]-4-bromophenyl] acetate

C25H19BrN4O7 — CID 98222623

IUPAC[2-[(2R)-3-acetyl-2-[4-[(3-nitrobenzoyl)amino]phenyl]-2H-1,3,4-oxadiazol-5-yl]-4-bromophenyl] acetate
SMILESCC(=O)Oc1ccc(Br)cc1C1=NN(C(C)=O)[C@@H](c2ccc(NC(=O)c3cccc([N+](=O)[O-])c3)cc2)O1
InChIInChI=1S/C25H19BrN4O7/c1-14(31)29-25(37-24(28-29)21-13-18(26)8-11-22(21)36-15(2)32)16-6-9-19(10-7-16)27-23(33)17-4-3-5-20(12-17)30(34)35/h3-13,25H,1-2H3,(H,27,33)/t25-/m1/s1
InChIKeyRODWSPAARDRTJZ-RUZDIDTESA-N
MW567.35 g/mol
LogP4.77
Rot. Bonds6

About [2-[(2R)-3-acetyl-2-[4-[(3-nitrobenzoyl)amino]phenyl]-2H-1,3,4-oxadiazol-5-yl]-4-bromophenyl] acetate

[2-[(2R)-3-acetyl-2-[4-[(3-nitrobenzoyl)amino]phenyl]-2H-1,3,4-oxadiazol-5-yl]-4-bromophenyl] acetate (PubChem CID 98222623) has the molecular formula C25H19BrN4O7 and a molecular weight of 567.35 g/mol. Its IUPAC name is [2-[(2R)-3-acetyl-2-[4-[(3-nitrobenzoyl)amino]phenyl]-2H-1,3,4-oxadiazol-5-yl]-4-bromophenyl] acetate.

Molecular Properties

Compound Name[2-[(2R)-3-acetyl-2-[4-[(3-nitrobenzoyl)amino]phenyl]-2H-1,3,4-oxadiazol-5-yl]-4-bromophenyl] acetate
PubChem CID98222623
Molecular FormulaC25H19BrN4O7
Molecular Weight567.35 g/mol
Exact Mass566.04
IUPAC Name[2-[(2R)-3-acetyl-2-[4-[(3-nitrobenzoyl)amino]phenyl]-2H-1,3,4-oxadiazol-5-yl]-4-bromophenyl] acetate
SMILESCC(=O)Oc1ccc(Br)cc1C1=NN(C(C)=O)[C@@H](c2ccc(NC(=O)c3cccc([N+](=O)[O-])c3)cc2)O1
InChIInChI=1S/C25H19BrN4O7/c1-14(31)29-25(37-24(28-29)21-13-18(26)8-11-22(21)36-15(2)32)16-6-9-19(10-7-16)27-23(33)17-4-3-5-20(12-17)30(34)35/h3-13,25H,1-2H3,(H,27,33)/t25-/m1/s1
InChIKeyRODWSPAARDRTJZ-RUZDIDTESA-N
XLogP4.77
TPSA140.44 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500567.35
LogP ≤ 54.77
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'phenol_ester', 'substructure': 'N/A'}

Analyze [2-[(2R)-3-acetyl-2-[4-[(3-nitrobenzoyl)amino]phenyl]-2H-1,3,4-oxadiazol-5-yl]-4-bromophenyl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [2-[(2R)-3-acetyl-2-[4-[(3-nitrobenzoyl)amino]phenyl]-2H-1,3,4-oxadiazol-5-yl]-4-bromophenyl] acetate?
The IUPAC name of [2-[(2R)-3-acetyl-2-[4-[(3-nitrobenzoyl)amino]phenyl]-2H-1,3,4-oxadiazol-5-yl]-4-bromophenyl] acetate (CID 98222623) is [2-[(2R)-3-acetyl-2-[4-[(3-nitrobenzoyl)amino]phenyl]-2H-1,3,4-oxadiazol-5-yl]-4-bromophenyl] acetate.
What is the SMILES notation for [2-[(2R)-3-acetyl-2-[4-[(3-nitrobenzoyl)amino]phenyl]-2H-1,3,4-oxadiazol-5-yl]-4-bromophenyl] acetate?
The canonical SMILES for [2-[(2R)-3-acetyl-2-[4-[(3-nitrobenzoyl)amino]phenyl]-2H-1,3,4-oxadiazol-5-yl]-4-bromophenyl] acetate is CC(=O)Oc1ccc(Br)cc1C1=NN(C(C)=O)[C@@H](c2ccc(NC(=O)c3cccc([N+](=O)[O-])c3)cc2)O1.
What is the InChIKey of [2-[(2R)-3-acetyl-2-[4-[(3-nitrobenzoyl)amino]phenyl]-2H-1,3,4-oxadiazol-5-yl]-4-bromophenyl] acetate?
The InChIKey is RODWSPAARDRTJZ-RUZDIDTESA-N. The full InChI is InChI=1S/C25H19BrN4O7/c1-14(31)29-25(37-24(28-29)21-13-18(26)8-11-22(21)36-15(2)32)16-6-9-19(10-7-16)27-23(33)17-4-3-5-20(12-17)30(34)35/h3-13,25H,1-2H3,(H,27,33)/t25-/m1/s1.
What are the key properties of [2-[(2R)-3-acetyl-2-[4-[(3-nitrobenzoyl)amino]phenyl]-2H-1,3,4-oxadiazol-5-yl]-4-bromophenyl] acetate?
[2-[(2R)-3-acetyl-2-[4-[(3-nitrobenzoyl)amino]phenyl]-2H-1,3,4-oxadiazol-5-yl]-4-bromophenyl] acetate has a molecular weight of 567.35 g/mol, XLogP of 4.77, 6 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for [2-[(2R)-3-acetyl-2-[4-[(3-nitrobenzoyl)amino]phenyl]-2H-1,3,4-oxadiazol-5-yl]-4-bromophenyl] acetate is sourced from PubChem (CID 98222623), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).